netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 3: Respiratory system - Full Section
Notes:

MHRA:Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects

Inhalers

The following acronyms may be mentioned in this section in reference to inhalers

  • MDI- Metered dose inhaler
  • DPI- Dry powder inhaler
  • BAA- Breath actuated aerosol
  • ICS- Inhaled corticosteroid
  • SABA- Short-acting bronchodilator
  • LABA- Long-acting bronchodilator
  • SAMA- Short-acting muscarinic
  • LAMA - Long-acting muscarinic
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
03.01 Bronchodilators (0,0)
03.01.01 Adrenoceptor agonists (0,0)
03.01.01.01 Selective Beta2 agonists (0,1)
Short-acting beta2 agonists (6,1)
Long-acting beta2 agonists (2,1)
03.01.01.02 Other adrenoceptor agonists (0,2)
03.01.02 Antimuscarinic bronchodilators (5,1)
Short Acting Anti-muscarinic Bronchodilators (0,0)
Long Acting Anti-muscarinic Bronchodilators (0,0)
03.01.03 Theophylline (3,0)
03.01.04 LAMA plus LABA (2,4)
03.01.05 Peak flow meters, inhaler devices and nebulisers (0,0)
Peak flow meters (2,4)
Drug delivery devices (5,9)
03.02 Corticosteroids (0,9)
03.02.01 Inhaled corticosteroids (ICS) (4,0)
03.02.02 Combination products (ICS+LABA) for asthma (0,0)
Low dose (3,2)
Moderate dose (3,3)
High dose (3,2)
03.02.03 Combination products (ICS+LABA) for COPD (2,0)
Triple Therapy products for COPD (2,0)
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
03.03.01 Cromoglicate and related therapy (0,4)
03.03.02 Leukotriene receptor antagonists (1,1)
03.03.03 Phosphodiesterase type-4 inhibitors (1,0)
03.04 Antihistamines, hyposensitisation, and allergic emergencies (0,0)
03.04.01 Antihistamines (0,0)
Non-sedating antihistamines (3,6)
Sedating antihistamines (2,5)
03.04.02 Allergen Immunotherapy (1,5)
Omalizumab (2,0)
03.04.03 Allergic emergencies (0,0)
Anaphylaxis (1,3)
Angioedema (2,3)
03.05 Respiratory stimulants and pulmonary surfactants (0,0)
03.05.01 Respiratory stimulants (2,0)
03.05.02 Pulmonary surfactants (1,1)
03.06 Oxygen (0,0)
03.07 Mucolytics (1,5)
Dornase alfa (1,0)
Hypertonic Sodium Chloride (3,0)
Mannitol (1,0)
03.08 Aromatic inhalations (0,2)
03.09 Cough preparations (0,0)
03.09.01 Cough suppressants (2,4)
Palliative care (0,0)
03.09.02 Expectorant and demulcent cough preparations (1,2)
03.10 Systemic nasal decongestants (0,1)
03.11 Antifibrotics (1,2)
netFormulary